We received an European grant of 3.5 million for research into inflammatory bowel disease
Together with the Erasmus MC Rotterdam, the Helmholtz Zentrum in Munich and Statice in Besançon, France, we received a grant of 3.5 million euros for research in inflammatory bowel disease (IBD). This research will focus on the distribution of medication with the use of multispectral fluorescence endoscopy.
Prof. Dr. Wouter Nagengast will lead this research together with the hospital pharmacist Prof. Dr. Marjolijn Lub-de Hooge. The research will focus on the local distribution and concentration of expensive medication used to treat IBD such as ulcerative colitis or chron’s disease with the use of multispectral fluorescence endoscopy.
Treatment of IBD often involves immunomodulatory drugs and is complex. Above all, it is often unclear which medication will give the best results in individual patients. Using a new multispectral fluorescence endoscope and fluorescent medication the distribution and concentration of the medication can be visualized and quantified in real-time.
